| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Defects, Congenital | 7 | 2021 | 933 | 1.99 | Why? |
| Fontan Procedure | 2 | 2018 | 42 | 1.42 | Why? |
| Cooking and Eating Utensils | 1 | 2020 | 10 | 0.87 | Why? |
| Ventricular Function, Left | 3 | 2018 | 1555 | 0.84 | Why? |
| Heart Ventricles | 2 | 2018 | 1139 | 0.76 | Why? |
| Atherosclerosis | 2 | 2017 | 768 | 0.74 | Why? |
| Hepatitis B, Chronic | 6 | 2021 | 616 | 0.70 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.68 | Why? |
| Echocardiography | 4 | 2019 | 3661 | 0.68 | Why? |
| Hong Kong | 14 | 2021 | 3361 | 0.60 | Why? |
| American Heart Association | 1 | 2017 | 347 | 0.59 | Why? |
| Fomites | 1 | 2020 | 709 | 0.52 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.42 | Why? |
| Gastrointestinal Microbiome | 5 | 2021 | 1961 | 0.35 | Why? |
| Systole | 2 | 2018 | 252 | 0.33 | Why? |
| Alanine Transaminase | 3 | 2021 | 1329 | 0.28 | Why? |
| Latent Tuberculosis | 2 | 2019 | 324 | 0.28 | Why? |
| Dysbiosis | 2 | 2021 | 685 | 0.27 | Why? |
| Disease Progression | 4 | 2018 | 13580 | 0.25 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2021 | 12361 | 0.24 | Why? |
| Feces | 3 | 2020 | 4235 | 0.24 | Why? |
| Tuberculin Test | 2 | 2019 | 141 | 0.23 | Why? |
| Coronary Artery Disease | 1 | 2016 | 2570 | 0.23 | Why? |
| Guanine | 2 | 2018 | 146 | 0.22 | Why? |
| Wood | 1 | 2020 | 29 | 0.22 | Why? |
| Cyanosis | 1 | 2021 | 100 | 0.21 | Why? |
| Mycobiome | 1 | 2020 | 43 | 0.21 | Why? |
| Liver | 3 | 2020 | 4007 | 0.21 | Why? |
| Poly I-C | 1 | 2021 | 176 | 0.21 | Why? |
| Cytomegalovirus Retinitis | 1 | 2019 | 11 | 0.21 | Why? |
| Disease Management | 2 | 2019 | 6841 | 0.21 | Why? |
| HIV Infections | 4 | 2019 | 11620 | 0.20 | Why? |
| Joint Diseases | 1 | 2020 | 122 | 0.19 | Why? |
| Ganciclovir | 1 | 2019 | 97 | 0.19 | Why? |
| Liver Cirrhosis | 3 | 2018 | 1810 | 0.18 | Why? |
| Tachycardia, Supraventricular | 1 | 2018 | 52 | 0.18 | Why? |
| Carcinoma, Hepatocellular | 2 | 2018 | 1222 | 0.18 | Why? |
| Arterial Switch Operation | 1 | 2017 | 20 | 0.18 | Why? |
| Lymphoma, Primary Effusion | 1 | 2017 | 11 | 0.18 | Why? |
| Tetralogy of Fallot | 1 | 2018 | 43 | 0.18 | Why? |
| Transposition of Great Vessels | 1 | 2017 | 30 | 0.18 | Why? |
| Tenofovir | 2 | 2018 | 449 | 0.18 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2019 | 94 | 0.17 | Why? |
| Cardiac Care Facilities | 1 | 2017 | 79 | 0.17 | Why? |
| Echocardiography, Doppler | 1 | 2019 | 269 | 0.16 | Why? |
| Fungi | 1 | 2020 | 471 | 0.16 | Why? |
| Aspartate Aminotransferases | 2 | 2021 | 1394 | 0.16 | Why? |
| Herpesvirus 8, Human | 1 | 2017 | 97 | 0.16 | Why? |
| Elasticity Imaging Techniques | 1 | 2018 | 194 | 0.16 | Why? |
| Liver Neoplasms | 2 | 2018 | 1666 | 0.16 | Why? |
| Adult | 30 | 2021 | 244371 | 0.16 | Why? |
| Sarcoma, Kaposi | 1 | 2017 | 97 | 0.16 | Why? |
| Cardiac Surgical Procedures | 2 | 2021 | 1931 | 0.15 | Why? |
| Carotid Intima-Media Thickness | 1 | 2017 | 179 | 0.15 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.15 | Why? |
| Anthropometry | 1 | 2016 | 233 | 0.15 | Why? |
| Gastrointestinal Tract | 2 | 2021 | 1113 | 0.15 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.15 | Why? |
| Tachycardia, Ventricular | 1 | 2018 | 251 | 0.14 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.14 | Why? |
| Catheter-Related Infections | 1 | 2019 | 381 | 0.14 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.13 | Why? |
| End Stage Liver Disease | 1 | 2018 | 418 | 0.13 | Why? |
| Male | 34 | 2021 | 367725 | 0.13 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.13 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.13 | Why? |
| Rheumatic Diseases | 2 | 2020 | 2675 | 0.13 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.13 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.13 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Risk Assessment | 6 | 2021 | 25439 | 0.12 | Why? |
| Acute Lung Injury | 1 | 2021 | 904 | 0.12 | Why? |
| Female | 31 | 2021 | 380317 | 0.12 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2019 | 552 | 0.12 | Why? |
| Education, Medical, Continuing | 1 | 2019 | 638 | 0.12 | Why? |
| Humans | 47 | 2021 | 930598 | 0.12 | Why? |
| Retrospective Studies | 14 | 2021 | 105322 | 0.12 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.12 | Why? |
| HIV | 1 | 2019 | 1116 | 0.12 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.12 | Why? |
| Eye Infections, Viral | 1 | 2019 | 517 | 0.11 | Why? |
| Hypertension, Pulmonary | 1 | 2021 | 970 | 0.11 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.11 | Why? |
| Cardiac Catheterization | 1 | 2019 | 882 | 0.11 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.11 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.10 | Why? |
| California | 1 | 2016 | 2047 | 0.10 | Why? |
| Young Adult | 12 | 2020 | 93724 | 0.10 | Why? |
| Superior Vena Cava Syndrome | 1 | 2008 | 26 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Tuberculosis, Lymph Node | 1 | 2008 | 27 | 0.09 | Why? |
| Adolescent | 9 | 2020 | 86841 | 0.09 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.09 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.09 | Why? |
| Antiviral Agents | 7 | 2020 | 41703 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Longitudinal Studies | 3 | 2020 | 9893 | 0.09 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.09 | Why? |
| Saliva | 2 | 2020 | 4679 | 0.08 | Why? |
| Cardiology | 2 | 2019 | 2873 | 0.08 | Why? |
| Clinical Competence | 2 | 2019 | 3263 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.08 | Why? |
| Anti-HIV Agents | 1 | 2019 | 2209 | 0.08 | Why? |
| Interferon-gamma Release Tests | 2 | 2019 | 253 | 0.08 | Why? |
| Tracheostomy | 1 | 2020 | 1963 | 0.08 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.08 | Why? |
| Registries | 4 | 2019 | 12327 | 0.08 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.08 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.08 | Why? |
| Nasopharynx | 3 | 2020 | 10224 | 0.07 | Why? |
| Education, Medical, Graduate | 1 | 2019 | 2082 | 0.07 | Why? |
| Metapneumovirus | 1 | 2007 | 465 | 0.07 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2014 | 1234 | 0.07 | Why? |
| Paramyxoviridae Infections | 1 | 2007 | 364 | 0.07 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.07 | Why? |
| Bilirubin | 1 | 2006 | 503 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.06 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.06 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.06 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Coinfection | 2 | 2019 | 6820 | 0.06 | Why? |
| Azithromycin | 1 | 2017 | 3943 | 0.06 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.06 | Why? |
| Transferases | 1 | 2021 | 28 | 0.06 | Why? |
| Child | 7 | 2020 | 70012 | 0.06 | Why? |
| Aged | 16 | 2021 | 215776 | 0.06 | Why? |
| Radiography, Thoracic | 2 | 2018 | 5486 | 0.06 | Why? |
| Prospective Studies | 4 | 2020 | 43301 | 0.05 | Why? |
| Community-Acquired Infections | 2 | 2020 | 2328 | 0.05 | Why? |
| Aspergillus niger | 1 | 2020 | 29 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.05 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.05 | Why? |
| DNA, Fungal | 1 | 2020 | 95 | 0.05 | Why? |
| Aspergillus flavus | 1 | 2020 | 51 | 0.05 | Why? |
| Specialty Boards | 1 | 2019 | 115 | 0.05 | Why? |
| Hepatitis B Surface Antigens | 1 | 2021 | 305 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Medical History Taking | 1 | 2021 | 350 | 0.05 | Why? |
| Hypertrophy, Right Ventricular | 1 | 2018 | 33 | 0.05 | Why? |
| Candida albicans | 1 | 2020 | 217 | 0.05 | Why? |
| Ventricular Pressure | 1 | 2017 | 25 | 0.05 | Why? |
| Pilot Projects | 2 | 2020 | 5182 | 0.04 | Why? |
| Isoniazid | 1 | 2018 | 105 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.04 | Why? |
| Antitubercular Agents | 2 | 2018 | 775 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Interleukin-1 | 1 | 2021 | 438 | 0.04 | Why? |
| Causality | 1 | 2021 | 857 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.04 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.04 | Why? |
| DNA, Bacterial | 1 | 2021 | 835 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Treatment Outcome | 6 | 2018 | 51732 | 0.04 | Why? |
| Candida | 1 | 2020 | 425 | 0.04 | Why? |
| Biopsy | 2 | 2018 | 2811 | 0.04 | Why? |
| DNA | 1 | 2021 | 778 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2018 | 388 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2019 | 1517 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2019 | 458 | 0.03 | Why? |
| Metagenomics | 1 | 2020 | 823 | 0.03 | Why? |
| Gastrointestinal Agents | 1 | 2018 | 393 | 0.03 | Why? |
| United States | 2 | 2019 | 46150 | 0.03 | Why? |
| Hepatitis B virus | 1 | 2021 | 882 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Biological Therapy | 1 | 2018 | 456 | 0.03 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.03 | Why? |
| SARS Virus | 2 | 2007 | 13021 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Geographic Information Systems | 1 | 2017 | 507 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Ribavirin | 1 | 2020 | 1182 | 0.03 | Why? |
| Oseltamivir | 1 | 2017 | 583 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2018 | 711 | 0.03 | Why? |
| Visual Acuity | 1 | 2019 | 790 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Educational Measurement | 1 | 2019 | 930 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.03 | Why? |
| Fellowships and Scholarships | 1 | 2019 | 931 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Neutrophils | 1 | 2006 | 5476 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.02 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.02 | Why? |
| New York | 1 | 2017 | 2488 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Influenza A virus | 1 | 2021 | 2234 | 0.02 | Why? |
| Parkinson Disease | 1 | 2021 | 1414 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Curriculum | 1 | 2019 | 3083 | 0.02 | Why? |
| Cross Infection | 1 | 2007 | 8675 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Lymph Nodes | 1 | 2008 | 1060 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2007 | 27595 | 0.01 | Why? |
| Travel | 1 | 2017 | 7220 | 0.01 | Why? |
| Inpatients | 1 | 2014 | 5161 | 0.01 | Why? |
| Stroke | 1 | 2021 | 8839 | 0.01 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Leukocyte Count | 1 | 2006 | 3178 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2006 | 7220 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2008 | 25144 | 0.00 | Why? |
| Infection Control | 1 | 2007 | 23131 | 0.00 | Why? |
| Health Personnel | 1 | 2007 | 29646 | 0.00 | Why? |